News

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

HANOVER, Md., May 30, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company focused on developing…

7 months ago

Specific Health Guidance Service Utilizing the “Lav” Healthcare App: Surpassed 100 cumulative contracted companies and 10,000 cumulative supported individuals!

TOKYO, May 30, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) ("MEDIROM," "we,” “us” or “our”), a holistic…

7 months ago

Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference

CLEVELAND, May 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Ph.D., Chief Executive…

7 months ago

Hapbee Launches Redesigned Mobile App with AI-Powered Discovery Engine, Expanded Vibe Library and Real-Time In-App Support to Enhance Personalization, Usability, and User Engagement

Company Also Updates Status of Audited Financial StatementsVANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV:…

7 months ago

Radical Clean Solutions Ltd. Terminates Asset Purchase Agreement with AgriForce Growing Systems Ltd. and Files Lawsuit for Breach of Contract

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Radical Clean Solutions Ltd. (“Radical” or the “Company”), a Nevada corporation headquartered…

7 months ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

7 months ago

Shareholder Update

May 30, 2025 Biodexa Pharmaceuticals PLC Shareholder Update Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (Nasdaq: BDRX), a clinical stage…

7 months ago

Syncromune® Announces First Patient Dosed in LEGION-100 Phase 2a Trial of SYNC-T® Therapy SV-102 for Patients with Metastatic Castration-Resistant Prostate Cancer

SYNC-T Therapy SV-102 combines partial tumor oncolysis with a multi-target biologic drug to provide a novel, personalized therapeutic approach for…

7 months ago

Noom Launches Free Menopause Education Hub in Partnership with Menopause Advocate Tamsen Fadal

Leveraging Noom’s evidence-based behavior change program, the Menopause Education Hub provides vital guidance for women experiencing the hormonal transitions of…

7 months ago

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq:…

7 months ago